Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study
Krishnan A, Schneider CV, Hadi Y, et al.
Diabetologia. Pub. online 20 Dec 2023.
Leggi